Implications of long-term medication of oral steroids and antimalarial drugs in primary Sjögren's syndrome

International Immunopharmacology

Volumn 11, Issue 12, 2011, Pages 2125-2129

  Reksten, Tove Ragna ^a   Brokstad, Karl A ^a   Jonsson, Roland ^a,b   Brun, Johan G ^a,b   Jonsson, Malin V ^a  

^a UNIVERSITY OF BERGEN   (Norway)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

Autoantibodies; Autoimmunity; Cytokines; Hydroxychlorochin; Oral steroids; Prednisolone

Indexed keywords

ANTICOAGULANT AGENT; ANTILIPEMIC AGENT; ANTIMALARIAL AGENT; AUTOANTIBODY; CYTOKINE; GAMMA INTERFERON; HYDROXYCHLOROQUINE; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 10; INTERLEUKIN 12P40; INTERLEUKIN 13; INTERLEUKIN 15; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISOLONE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ANTIBODY BLOOD LEVEL; ARTHRALGIA; ARTICLE; CONTROLLED STUDY; DRY SKIN; FEMALE; HUMAN; JOINT SWELLING; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MYALGIA; PRIMARY SJOEGREN SYNDROME; PRIMARY SJOGREN SYNDROME; PRIORITY JOURNAL; SJOEGREN SYNDROME;

ADRENAL CORTEX HORMONES; ADULT; ANTIMALARIALS; AUTOANTIBODIES; COHORT STUDIES; CYTOKINES; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; SJOGREN'S SYNDROME; TREATMENT OUTCOME; YOUNG ADULT;

EID: 81855170198     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2011.09.006     Document Type: Article

References (34)

1. H. Garberg, R. Jonsson, and K.A. Brokstad The serological pattern of autoantibodies to the Ro52, Ro60, and La48 autoantigens in primary Sjögren's syndrome patients and healthy controls Scand J Rheumatol 34 2005 49 55 (Pubitemid 40445059)
2. R. Jonsson, S. Bowman, and T.P. Gordon Sjögren's syndrome W.J. Koopman, L.W. Moreland, Arthritis and allied conditions - a textbook of rheumatology 15th ed. 2005 Lippincott Williams and Wilkins Philadelphia 1681 1705
3. S. Candon, J. Gottenberg, D. Bengoufa, L. Chatenoud, and X. Mariette Quantitative assessment of antibodies to ribonucleoproteins in primary Sjögren's syndrome: correlation with B cell biomarkers and disease activity Ann Rheum Dis 68 2008 1208 1212
4. N.M. Moutsopoulos, G.E. Katsifis, N. Angelov, R.A. Leakan, V. Sankar, and S. Pillemer Lack of efficacy of etanercept in Sjögren's syndrome correlates with failed suppression of tumour necrosis factor α and systemic immune activation Ann Rheum Dis 67 10 2008 1437 1443
5. M. Ramos-Casals, M. Garcia-Carrasco, M.P. Brito, A. Lopez-Soto, and J. Font Autoimmunity and geriatrics: clinical significance of autoimmune manifestations in the elderly Lupus 12 5 2003 341 355 (Pubitemid 36596978)
6. T.R. Reksten, M.V. Jonsson, E.A. Szyszko, J.G. Brun, R. Jonsson, and K.A. Brokstad Cytokine and autoantibody profiling related to histopathological features in primary Sjögren's syndrome Rheumatology 48 9 2009 1102 1106
7. R. Jonsson, H.-J. Haga, and T. Gordon Current concepts on diagnosis, autoantibodies and therapy in Sjögren's syndrome Scand J Rheumatol 29 6 2000 341 348 (Pubitemid 32014832)
8. A. Thanou-Stavraki, and J.A. James Primary Sjögren's syndrome: current and prospective therapies Semin Arthritis Rheum 37 5 2008 273 292 (Pubitemid 351389478)
9. H. Seitsalo, R.K. Niemelä, M. Marinescu-Gava, T. Vuotila, L. Tjäderhane, and T. Salo Effectiveness of low-dose doxycycline (LDD) on clinical symptoms of Sjögren's syndrome: a randomized, double-blind, placebo controlled cross-over study J Negat Results Biomed 2007 11
10. E. Alpöz, P. Güneri, G. Önder, H. Cankaya, Y. Kabasakal, and T. Köse The efficacy of Xialine in patients with Sjögren's syndrome: a single-blind, cross-over study Clin Oral Invest 2 2008 165 172
11. A. Hartkamp, R. Geenen, G.L. Godaert, H. Bootsma, A.A. Kruize, and J.W. Bijlsma Effect of dehydroepiandrosterone administration on fatigue, well-being, and functioning in women with primary Sjögren syndrome: a randomised controlled trial Ann Rheum Dis 1 2008 91 97
12. X. Mariette, P. Ravaud, S. Steinfeld, G. Baron, J. Goetz, and E. Hachulla Inefficacy of infliximab in primary Sjögren's syndrome: results of the randomized, controlled trial of remicade in primary Sjögren's syndrome (TRIPSS) Arthritis Rheum 50 4 2004 1270 1276 (Pubitemid 38488821)
13. V. Sankar, M.T. Brennan, M.R. Kok, R.A. Leakan, J.A. Smith, and J. Manny Etanercept in Sjögren's syndrome: a twelve-week randomized, double-blind, placebo-controlled pilot clinical trial Arthritis Rheum 50 7 2004 2240 2245 (Pubitemid 38930815)
14. S.D. Steinfeld, P. Demols, and T. Appelboom Infliximab in primary Sjögren's syndrome: one-year followup Arthritis Rheum 46 12 2002 3301 3303 (Pubitemid 35453540)
15. J.O. Pers, V. Devauchelle, C. Daridon, B. Bendaoud, R. Le Berre, and A. Bordron BAFF-modulated repopulation of B lymphocytes in the blood and salivary glands of rituximab-treated patients with Sjögren's syndrome Arthritis Rheum 5 2007 1464 1477 (Pubitemid 46764075)
16. J. James, X. Kim-Howard, B. Bruner, M. Jonsson, M. McClain, and M. Arbuckle Hydroxychloroquine sulfate treatment is associated with later onset of systemic lupus erythematosus Lupus 16 6 2007 401 409 (Pubitemid 47122213)
17. C. Vitali, S. Bombardieri, R. Jonsson, H.M. Moutsopoulos, E.L. Alexander, and S.E. Carsons Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group Ann Rheum Dis 61 6 2002 554 558 (Pubitemid 34539104)
18. M. Tishler, I. Yaron, I. Shirazi, and M. Yaron Hydroxychloroquine treatment for primary Sjögren's syndrome: its effect on salivary and serum inflammatory markers Ann Rheum Dis 58 1999 253 256 (Pubitemid 29191659)
19. R. Fox, R. Dixon, V. Guarrasi, and S. Krubel Treatment of primary Sjögren's syndrome with hydroxychloroquine: a retrospective, open-label study Lupus 5 1-suppl 1996 S31 S36
20. D.J. Wallace Antimalarials - the 'real' advance in lupus Lupus 10 6 2001 385 387 (Pubitemid 32578610)
21. D. Wallace, M. Linker-Israeli, S. Hyun, J. Klinenberg, and V. Stecher The effect of hydroxychloroquine therapy on serum levels of immunoregulatory molecules in patients with systemic lupus erythematosus J Rheumatol 21 2 1994 375 376 (Pubitemid 24078865)
22. C.-H. Jang, J.-H. Choi, M.-S. Byun, and D.-M. Jue Chloroquine inhibits production of TNF-α, IL-1β and IL-6 from lipopolysaccharide- stimulated human monocytes/macrophages by different modes Rheumatology 45 6 2006 703 710 (Pubitemid 43985338)
23. P. Gøtzsche, and H.K. Johansen Short-term low-dose corticosteroids vs placebo and non-steroidal antiinflammatory drugs in rheumatoid arthritis Cochrane Database of Systematic Reviews 2005 Issue 1. Art. No.: CD000189. doi: 10.1002/14651858.CD000189.pub2
24. J.R. de Andrade, J.N. McCormick, and A.G.S. Hill Small doses of prednisolone in the managment of rheumatoid arthritis Ann Rheum Dis 23 1964 158 162
25. Prednisolone 1 mg Tablets - PL 29831/0177. Wockhardt UK Ltd 31/03/2008.
26. Q. Xu, E. Goleva, and D.Y.M. Leung NK cells induce corticosteroid unresponsiveness in B-cells treated with IL-15 J Allergy Clin Immunol 113 2, Supplement 1 2004 S214 S
27. E. Goleva, L.-b. Li, and D.Y.M. Leung IFN-γ reverses IL-2- and IL-4-mediated T-cell steroid resistance Am J Respir Cell Mol Biol 40 2 2009 223 230
28. L. Xu, Z. Xu, and M. Xu Glucocorticoid treatment restores the impaired suppressive function of regulatory T cells in patients with relapsing-remitting multiple sclerosis Clin Exp Immunol 158 1 2009 26 30
29. C. Luther, E. Adamopoulou, C. Stoeckle, V. Brucklacher-Waldert, D. Rosenkranz, and L. Stoltze Prednisolone treatment induces tolerogenic dendritic cells and a regulatory milieu in myasthenia gravis patients J Immunol 183 2 2009 841 848
30. S. Miyawaki, S. Nishiyama, and K. Matoba Efficacy of low-dose prednisolone maintenance for saliva production and serological abnormalities in patients with primary Sjögren's syndrome Intern Med 38 12 1999 938 943 (Pubitemid 30020544)
31. K. Haldorsen, K. Moen, H. Jacobsen, R. Jonsson, and J.G. Brun Exocrine function in primary Sjögren's syndrome: natural course and prognostic factors Ann Rheum Dis 67 7 2008 949 954 (Pubitemid 351956656)
32. L.H. Silveira, C.L. Hubble, L.J. Jara, S. Saway, P. MartÌnez- Osuna, and M.J. Seleznick Prevention of anticardiolipin antibody-related pregnancy losses with prednisone and aspirin Am J Med 93 4 1992 403 411
33. M.C. Kapetanovic, T. Saxne, A. Sjoholm, L. Truedsson, G. Jonsson, and P. Geborek Influence of methotrexate, TNF blockers and prednisolone on antibody responses to pneumococcal polysaccharide vaccine in patients with rheumatoid arthritis Rheumatology 45 1 2006 106 111 (Pubitemid 43033885)
34. K. Tsuzaka, T. Ogasawara, T. Tojo, H. Fuji, Y. Tsukatani, and A. Kubo Relationship between autoantibodies and clinical parameters in Sjögren's syndrome Scand J Rheumatol 22 1 1993 1 9 (Pubitemid 23064765)